Nicox SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
NicOx SA completes acquisition of Eupharmed
NicOx SA:Says it has completed the acquisition of Eupharmed, a privately-held Italian ophthalmic company.
- Share this
- Digg this